SG11201405778WA - Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections - Google Patents

Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections

Info

Publication number
SG11201405778WA
SG11201405778WA SG11201405778WA SG11201405778WA SG11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA SG 11201405778W A SG11201405778W A SG 11201405778WA
Authority
SG
Singapore
Prior art keywords
vaginal
prevention
treatment
amphoteric surfactants
biofilms
Prior art date
Application number
SG11201405778WA
Inventor
Christoph Abels
Ulrich Knie
Michael Soeberdt
Original Assignee
Wolff August Gmbh & Co Kg Arzneimittel Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolff August Gmbh & Co Kg Arzneimittel Dr filed Critical Wolff August Gmbh & Co Kg Arzneimittel Dr
Publication of SG11201405778WA publication Critical patent/SG11201405778WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201405778WA 2012-03-19 2013-03-19 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections SG11201405778WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261612680P 2012-03-19 2012-03-19
EP12160058 2012-03-19
PCT/EP2013/055706 WO2013139796A1 (en) 2012-03-19 2013-03-19 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections

Publications (1)

Publication Number Publication Date
SG11201405778WA true SG11201405778WA (en) 2014-10-30

Family

ID=49221873

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405778WA SG11201405778WA (en) 2012-03-19 2013-03-19 Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections

Country Status (13)

Country Link
US (1) US20150164837A1 (en)
EP (1) EP2827854A1 (en)
JP (1) JP2015510914A (en)
KR (1) KR20150002676A (en)
CN (1) CN104244942A (en)
AU (1) AU2013237576A1 (en)
CA (1) CA2865687A1 (en)
HK (1) HK1201189A1 (en)
MX (1) MX2014011218A (en)
NZ (1) NZ630347A (en)
RU (1) RU2014141897A (en)
SG (1) SG11201405778WA (en)
WO (1) WO2013139796A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201408243VA (en) 2012-06-13 2015-01-29 Evofem Inc Compositions and methods for enhancing the efficacy of contraceptive microbicides
JP2017078029A (en) * 2015-10-19 2017-04-27 アース製薬株式会社 Sterilization method and sterilization composition
EP3522879A4 (en) * 2016-10-04 2020-06-03 Evofem, Inc. Method of treatment and prevention of bacterial vaginosis
CN112469274B (en) * 2018-07-31 2023-10-10 金伯利-克拉克环球有限公司 Compositions comprising antimicrobial enhancers including amphocarboxylates and methods of increasing antimicrobial efficacy of the compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405323A (en) * 1981-09-08 1983-09-20 Sidney Auerbach Sanitary napkin
WO1990007325A1 (en) * 1988-12-30 1990-07-12 Edko Trading And Representation Company Limited A pessary containing antibacterial drugs
GB9810949D0 (en) * 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
US6723308B2 (en) * 2001-11-02 2004-04-20 Kenra, Llc Hair clarifying treatment
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
ES2464272T3 (en) * 2005-05-20 2014-06-02 Solvay Usa Inc. Structured Surfactant Compositions
PL2529723T3 (en) 2007-11-30 2016-09-30 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
CN102245155B (en) * 2008-12-08 2015-11-25 宝洁公司 There is the personal care composition of the object form of solubility porosu solid structure

Also Published As

Publication number Publication date
CN104244942A (en) 2014-12-24
AU2013237576A1 (en) 2014-09-25
KR20150002676A (en) 2015-01-07
EP2827854A1 (en) 2015-01-28
MX2014011218A (en) 2015-04-10
WO2013139796A1 (en) 2013-09-26
CA2865687A1 (en) 2013-09-26
US20150164837A1 (en) 2015-06-18
JP2015510914A (en) 2015-04-13
HK1201189A1 (en) 2015-08-28
RU2014141897A (en) 2016-05-20
NZ630347A (en) 2016-04-29

Similar Documents

Publication Publication Date Title
HRP20181364T1 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
HK1204914A1 (en) Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
PT2667849T (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
HK1209195A1 (en) Contact lens use in the treatment of an ophthalmologic condition
PL2627334T3 (en) Compositions for use in the treatment of viral infections
GB201319621D0 (en) Antimicrobial agents and their use in therapy
PL2854910T3 (en) Ceramide levels in the treatment and prevention of infections
EP2841064A4 (en) Use of n-acetylcysteine amide in the treatment of disease and injury
GB2515439B (en) Vesicular formulations for use in the treatment of reduced mobility
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1201189A1 (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
PL2845598T3 (en) Preparation for use in the prophylaxis and treatment of atypical osteoporosis
EP2709630A4 (en) Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections
HK1214511A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
PL2862576T3 (en) Microorganisms and compositions comprising them for use in the treatment or prevention of mastitis
ZA201308025B (en) The use of secnidazole in treating dental infections
PL2771016T3 (en) Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens
LT2863932T (en) Composition for use in the treatment of lymphedema
GB201208770D0 (en) Compounds for use in the treatment of adenovirus infections